Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection

Introduction The COVID-19 epidemic grows and there are clinical trials of antivirals. There is an opportunity to complement these trials with investigation of angiotensin II type 1 receptor blockers (ARBs) because an ARB (losartan) was effective in murine influenza pneumonia.Methods and analysis Our...

Full description

Bibliographic Details

Published in:	BMJ Open
Main Authors:	Joel Singer, Srinivas Murthy, Bin Du, Terry Lee, Michael O Harhay, John C Marshall, Zhiyong Peng, James A. Russell, Arthur Slutsky, Dave Sweet, David M Patrick, Matthew Cheng, Kevin D Burns
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-12-01
Online Access:	https://bmjopen.bmj.com/content/10/12/e040768.full